Elite Pharmaceuticals (ELTP) Share-based Compensation (IS) (2009 - 2026)
Elite Pharmaceuticals (ELTP) posted Share-based Compensation (IS) of $20,307 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 59.3% from $49,918 a year earlier and down 28.7% from the prior quarter.
Elite Pharmaceuticals (ELTP) Share-based Compensation (IS) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Share-based Compensation (IS) at Elite Pharmaceuticals was $123,043, down 45.4% year-over-year; for FY2026 (ended Mar 31, 2026), it was $176,507, down 22.4% from FY2025.
- Annual Share-based Compensation (IS) shows a five-year compound annual growth rate of 68.0% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Share-based Compensation (IS) was $227,565 in FY2025 (+42.3%), $159,921 in FY2024 (+306.7%), $39,325 in FY2023 (+174.0%) and $14,353 in FY2022 (+8.9%).
- The fiscal Q2 2027 figure stands as the lowest quarterly Share-based Compensation (IS) since fiscal Q1 2024.
- On a year-over-year basis, Share-based Compensation (IS) has declined in each of the last five quarters, with an average decline of 18.5% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation (IS) in the past five years was fiscal Q2 2024, with growth of 616.2%; the weakest was fiscal Q2 2027, with a decline of 59.3%.
- According to Business Quant data, Share-based Compensation (IS) for the three prior fiscal quarters was $28,476 (Q1 2027), $29,164 (Q4 2026) and $45,096 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,285.32 Bn | 1,258.94 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 685.79 Bn | 605.65 Bn | 17.30 Bn | - |
| 3 | AbbVie | 523.62 Bn | 491.63 Bn | 13.12 Bn | - |
| 4 | Merck | 360.92 Bn | 323.86 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 312.94 Bn | 286.18 Bn | - | - |
| 6 | Astrazeneca | 286.47 Bn | 259.99 Bn | 13.26 Bn | - |
| 7 | Amgen | 252.49 Bn | 204.14 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.77 Bn | 184.88 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.93 Bn | 112.29 Bn | 12.56 Bn | - |
| 10 | Elite Pharmaceuticals | 398.54 Mn | 271.95 Mn | 15.99 Mn | 20,307.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20,307.00 |
| Jun 30, 2026 | 28,476.00 |
| Mar 31, 2026 | 29,164.00 |
| Dec 31, 2025 | 45,096.00 |
| Sep 30, 2025 | 49,918.00 |
| Jun 30, 2025 | 52,329.00 |
| Mar 31, 2025 | 52,329.00 |
| Dec 31, 2024 | 70,578.00 |
| Sep 30, 2024 | 52,329.00 |
| Jun 30, 2024 | 52,329.00 |
| Mar 31, 2024 | 52,329.00 |
| Dec 31, 2023 | 49,815.00 |
| Sep 30, 2023 | 42,777.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 13,030.00 |
| Sep 30, 2022 | 5,973.00 |
| Jun 30, 2022 | 5,322.00 |
| Mar 31, 2022 | 3,736.00 |
| Dec 31, 2021 | 3,630.00 |
Elite Pharmaceuticals Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();